Surgical risk score predicts suboptimal debulking or a major perioperative complication in patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer

International Journal of Gynecological Cancer

Volumn 21, Issue 8, 2011, Pages 1422-1427

  Stashwick, Caitlin ^a   Post, Miriam D ^a   Arruda, Jaime S ^a   Spillman, Monique A ^a   Behbakht, Kian ^a   Davidson, Susan A ^a   Kelly, Michael Greg ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Neoadjuvant chemotherapy; Ovarian cancer; Surgical risk score (SRS)

Indexed keywords

ALBUMIN; CA 125 ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ALBUMIN BLOOD LEVEL; BLADDER INJURY; CANCER PATIENT; CANCER SIZE; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DEEP VEIN THROMBOSIS; FALSE NEGATIVE RESULT; FEMALE; HUMAN; INTESTINE INJURY; INTESTINE RESECTION; LIVER RESECTION; LUNG EMBOLISM; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALNUTRITION; MINIMAL RESIDUAL DISEASE; OUTCOME ASSESSMENT; OVARY CANCER; PERITONEUM CANCER; PREDICTIVE VALUE; PRIMARY TUMOR; PRIORITY JOURNAL; REOPERATION; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SPLENECTOMY; STOMA; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL PATIENT; SURGICAL RISK; UTERINE TUBE TUMOR; ARTICLE; GYNECOLOGIC SURGERY; HOSPITALIZATION; MIDDLE AGED; OVARY TUMOR; PERIOPERATIVE PERIOD; PERITONEUM TUMOR; REGRESSION ANALYSIS; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; FALLOPIAN TUBE NEOPLASMS; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; OVARIAN NEOPLASMS; PERIOPERATIVE PERIOD; PERITONEAL NEOPLASMS; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84857498751     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31822c7704     Document Type: Review

References (24)

1. Cannistra SA. Cancer of the ovary. N Engl J Med. 2004;351: 2519-2529.
2. Hoskins WJ, McGuire WP, Brady MF, et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol. 1994;170:974-980. (Pubitemid 24157907)
3. Chi DS, Eisenhauer EL, Lang J, et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol. 2006;103:559-564. (Pubitemid 44602167)
4. Vergote I, Trope CG, Amant F, et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010;363:943-953.
5. Vergote I, Dewever I, Tjalma W, et al. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol Oncol. 1998;71:431-436. (Pubitemid 29022333)
6. Hou JY, Kelly MG, Hu H, et al. Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease. Gynecol Oncol. 2007;105:211-217. (Pubitemid 46441463)
7. Kihn W, Rutke S, Spathe K, et al. Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis FIGO stage IIIC ovarian carcinoma. Cancer. 2001;92:2585-2591. (Pubitemid 33049442)
8. Chi DS, Venkatraman ES, Masson V, et al. The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. Gynecol Oncol. 2000;77:227-231. (Pubitemid 30317140)
9. Gemer O, Segal S, Kopmar A. Preoperative CA-125 level as a predictor of non-optimal cytoreduction of advanced epithelial ovarian cancer. Acta Obstet Gynecol Scand. 2001;80:583-585. (Pubitemid 32521301)
10. Memarzadeh S, Lee SB, Berek JS. CA-125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2003;13:120-124. (Pubitemid 37055464)
11. Alcazar JL, Miranda D, Unanue A, et al. CA-125 levels in predicting optimal cytoreductive surgery in patients with advanced epithelial ovarian carcinoma. Int J Gynecol Obstet. 2004;84:173-174. (Pubitemid 38210015)
12. Bristow RE, Duska LR, Lambrou NC, et al. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer. 2000;89: 1532-1540.
13. Meyer JI, Kennedy AW, Friedman RF, et al. Ovarian carcinoma: value of CT in predicting success of debulking surgery. Am J Radiol. 1995;165:875-878.
14. Dowdy SC, Mullany SA, Brandt KR, et al. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer. 2004;101:346-352. (Pubitemid 38890839)
15. Quayyum A, Coakley FV,Westphalen AC, et al. Role of CTand MR imaging in predicting optimal cytoredcution of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol. 2005;96:301-306. (Pubitemid 40127125)
16. Axtell AE, Lee MH, Bristow RE, et al. Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. J Clin Oncol. 2007;25:384-389. (Pubitemid 350002986)
17. Risum S, Hogdall C, Loft A, et al. Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomographyVa prospective study. Gynecol Oncol. 2008;108:265-270. (Pubitemid 351181445)
18. Jung DC, Kang S, Kim MJ, et al. Multidetector CT predictors of incomplete resection in primary cytoreduction of patients with advanced ovarian cancer. Eur Radiol. 2010;20:100-107.
19. Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248-1259. (Pubitemid 34177431)
20. Nelson BE, Rosenfield AT, Schwartz PE. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol. 1993;11:166-1172.
21. Richardson DL, Mariani A, Cilby WA. Risk factors for anastomotic leak after recto-sigmoid resection for ovarian cancer. Gynecol Oncol. 2006;103:667-672. (Pubitemid 44604496)
22. Bland AE, Everett EN, Pastore LM, et al. Predictors of suboptimal surgical cytoreduction in women with advanced epithelial ovarian cancer treated with initial chemotherapy. Int J Gynecol Cancer. 2008;18:629-636. (Pubitemid 352020188)
23. Fagotti A, Ferrandina G, Fanfani F, et al. A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. Ann Surg Oncol. 2006;13:1156-1161. (Pubitemid 44337976)
24. Brun JL, Rouzier R, Uzan S, et al. Eternal validation of a laparoscopic-based score to evaluate respectability of advanced ovarian cancers: clues for a simplified score. Gynecol Oncol. 2008;110:354-359.